CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Public ClinicalTrials.gov record NCT06690775. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Catalina-2: A Phase 2 Study Evaluating the Efficacy and Safety of TORL-1-23 in Women With Advanced Platinum-Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal and Fallopian Tube Cancers) Expressing Claudin 6
Study identification
- NCT ID
- NCT06690775
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- TORL Biotherapeutics, LLC
- Industry
- Enrollment
- 230 participants
Conditions and interventions
Conditions
Interventions
- Pegfilgrastim (drug) Drug
- TORL-1-23 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 19, 2024
- Primary completion
- Sep 30, 2027
- Completion
- Nov 30, 2027
- Last update posted
- Dec 22, 2025
2024 – 2027
United States locations
- U.S. sites
- 26
- U.S. states
- 18
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Hospital | Phoenix | Arizona | 85054 | Recruiting |
| SCRI - Arizona Oncology Associates, PC-HOPE | Tucson | Arizona | 85711 | Recruiting |
| City of Hope National Medical Center | Duarte | California | 91010 | Recruiting |
| Providence St. Jude Medical Center | Fullerton | California | 92835 | Recruiting |
| UCLA - JCCC Clinical Research Unit | Los Angeles | California | 90095 | Recruiting |
| Stanford Cancer Center | Palo Alto | California | 94304 | Recruiting |
| SCRI - Sansum Clinic | Santa Barbara | California | 93105 | Recruiting |
| Smilow Cancer Hospital at Yale - New Haven | New Haven | Connecticut | 06510 | Recruiting |
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | Recruiting |
| Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322 | Recruiting |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | Recruiting |
| SCRI - Maryland Oncology Hematology, P.A. | Annapolis | Maryland | 21401 | Recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| SCRI - Minnesota Oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | Recruiting |
| University of Minnesota | Minneapolis | Minnesota | 55404 | Recruiting |
| Mayo Clinic | Rochester | Minnesota | 55905 | Recruiting |
| Washington University | St Louis | Missouri | 63108 | Recruiting |
| Rutgers Cancer Institute | New Brunswick | New Jersey | 08901 | Recruiting |
| Duke Cancer Center | Durham | North Carolina | 27710 | Recruiting |
| The James Cancer Hospital and Solove Research Institute - Ohio State University | Columbus | Ohio | 43210 | Recruiting |
| Stephenson Cancer Center at the University of Oklahoma | Oklahoma City | Oklahoma | 73104 | Recruiting |
| SCRI - Northwest Cancer Specialists, P.C. | Portland | Oregon | 97227 | Recruiting |
| SCRI - Alliance Cancer Specialists, PC | Doylestown | Pennsylvania | 18901 | Recruiting |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104-4238 | Recruiting |
| SCRI - Texas Oncology | Fort Worth | Texas | 76104 | Recruiting |
| SCRI - Virginia Oncology Associates | Norfolk | Virginia | 23502 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06690775, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2025 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06690775 live on ClinicalTrials.gov.